1. Home
  2. GTBP vs LXEH Comparison

GTBP vs LXEH Comparison

Compare GTBP & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • LXEH
  • Stock Information
  • Founded
  • GTBP 1965
  • LXEH 2001
  • Country
  • GTBP United States
  • LXEH China
  • Employees
  • GTBP N/A
  • LXEH N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • LXEH Other Consumer Services
  • Sector
  • GTBP Health Care
  • LXEH Real Estate
  • Exchange
  • GTBP Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • GTBP 6.8M
  • LXEH 6.2M
  • IPO Year
  • GTBP N/A
  • LXEH 2020
  • Fundamental
  • Price
  • GTBP $2.25
  • LXEH $5.40
  • Analyst Decision
  • GTBP Strong Buy
  • LXEH
  • Analyst Count
  • GTBP 1
  • LXEH 0
  • Target Price
  • GTBP $11.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • GTBP 244.8K
  • LXEH 53.6K
  • Earning Date
  • GTBP 03-25-2025
  • LXEH 03-15-2025
  • Dividend Yield
  • GTBP N/A
  • LXEH N/A
  • EPS Growth
  • GTBP N/A
  • LXEH N/A
  • EPS
  • GTBP N/A
  • LXEH N/A
  • Revenue
  • GTBP N/A
  • LXEH $5,628,870.00
  • Revenue This Year
  • GTBP N/A
  • LXEH N/A
  • Revenue Next Year
  • GTBP N/A
  • LXEH N/A
  • P/E Ratio
  • GTBP N/A
  • LXEH N/A
  • Revenue Growth
  • GTBP N/A
  • LXEH N/A
  • 52 Week Low
  • GTBP $1.72
  • LXEH $1.95
  • 52 Week High
  • GTBP $10.66
  • LXEH $65.06
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 44.16
  • LXEH 58.06
  • Support Level
  • GTBP $2.01
  • LXEH $5.05
  • Resistance Level
  • GTBP $2.27
  • LXEH $5.52
  • Average True Range (ATR)
  • GTBP 0.22
  • LXEH 0.29
  • MACD
  • GTBP -0.01
  • LXEH -0.06
  • Stochastic Oscillator
  • GTBP 38.71
  • LXEH 74.57

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: